0001752724-23-292968.txt : 20231227 0001752724-23-292968.hdr.sgml : 20231227 20231227124244 ACCESSION NUMBER: 0001752724-23-292968 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20231031 FILED AS OF DATE: 20231227 DATE AS OF CHANGE: 20231227 PERIOD START: 20240731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LORD ABBETT DEVELOPING GROWTH FUND, INC. CENTRAL INDEX KEY: 0000276914 ORGANIZATION NAME: IRS NUMBER: 132958970 STATE OF INCORPORATION: MD FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-02871 FILM NUMBER: 231516220 BUSINESS ADDRESS: STREET 1: 90 HUDSON ST. CITY: JERSEY CITY STATE: NJ ZIP: 07302 BUSINESS PHONE: 201-827-2000 MAIL ADDRESS: STREET 1: 90 HUDSON ST. CITY: JERSEY CITY STATE: NJ ZIP: 07302 FORMER COMPANY: FORMER CONFORMED NAME: LORD ABBETT DEVELOPING GROWTH FUND INC /NEW/ DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DEVELOPING GROWTH SHARES INC DATE OF NAME CHANGE: 19600201 0000276914 S000006834 LORD ABBETT DEVELOPING GROWTH FUND INC C000018473 Class A LAGWX C000018475 Class C LADCX C000018476 Class P LADPX C000018477 Class I LADYX C000054855 Class F LADFX C000054856 Class R2 LADQX C000054857 Class R3 LADRX C000151972 Class R4 LADSX C000151973 Class R5 LADTX C000151974 Class R6 LADVX C000188220 Class F3 LOGWX NPORT-P 1 primary_doc.xml NPORT-P false 0000276914 XXXXXXXX S000006834 C000188220 C000018475 C000151974 C000151972 C000054856 C000151973 C000018473 C000018476 C000018477 C000054857 C000054855 LORD ABBETT DEVELOPING GROWTH FUND, INC. 811-02871 0000276914 549300HWJ2W28SDTJF85 90 HUDSON STREET JERSEY CITY 07302 201-827-2000 LORD ABBETT DEVELOPING GROWTH FUND INC S000006834 549300HWJ2W28SDTJF85 2024-07-31 2023-10-31 N 2098939471.34 26335196.04 2072604275.30 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 N 10X Genomics Inc 5493003Z6741WNLG7H43 10X Genomics Inc 88025U109 402217.00000000 NS USD 14190215.76000000 0.684656300728 Long EC CORP US N 1 N N N Inter Parfums Inc N/A Inter Parfums Inc 458334109 155453.00000000 NS USD 19759630.83000000 0.953372096423 Long EC CORP US N 1 N N N Piper Sandler Cos QUQDBTUSOAKFEVMRMF78 Piper Sandler Cos 724078100 158673.00000000 NS USD 22190419.05000000 1.070653926292 Long EC CORP US N 1 N N N Upwork Inc 5493004QJ6WWBXVE2S70 Upwork Inc 91688F104 869858.00000000 NS USD 9090016.10000000 0.438579434015 Long EC CORP US N 1 N N N DoubleVerify Holdings Inc N/A DoubleVerify Holdings Inc 25862V105 591906.00000000 NS USD 16472743.98000000 0.794784811375 Long EC CORP US N 1 N N N EnerSys 7ZS3DE5PN30BYUJFWP05 EnerSys 29275Y102 170407.00000000 NS USD 14583431.06000000 0.703628340141 Long EC CORP US N 1 N N N Trex Co Inc N/A Trex Co Inc 89531P105 628250.00000000 NS USD 35313932.50000000 1.703843464999 Long EC CORP US N 1 N N N Super Micro Computer Inc 54930022CZO1N2UGVW07 Super Micro Computer Inc 86800U104 112240.00000000 NS USD 26878112.80000000 1.296828011035 Long EC CORP US N 1 N N N nVent Electric PLC N/A nVent Electric PLC 000000000 551074.00000000 NS USD 26523191.62000000 1.279703604594 Long EC CORP IE N 1 N N N SiteOne Landscape Supply Inc 5299008LX7SBD4HIAU03 SiteOne Landscape Supply Inc 82982L103 210692.00000000 NS USD 29027036.84000000 1.400510323457 Long EC CORP US N 1 N N N Cava Group Inc N/A Cava Group Inc 148929102 502995.00000000 NS USD 15889612.05000000 0.766649583780 Long EC CORP US N 1 N N JFrog Ltd N/A JFrog Ltd 000000000 879440.00000000 NS USD 19778605.60000000 0.954287600180 Long EC CORP IL N 1 N N N Pacific Biosciences of California Inc 529900F1BWRE1M0KZN89 Pacific Biosciences of California Inc 69404D108 1364427.00000000 NS USD 8432158.86000000 0.406838824009 Long EC CORP US N 1 N N N iRhythm Technologies Inc 549300FJI72RJGDQS384 iRhythm Technologies Inc 450056106 140941.00000000 NS USD 11066687.32000000 0.533950810190 Long EC CORP US N 1 N N N Samsara Inc N/A Samsara Inc 79589L106 1742700.00000000 NS USD 40204089.00000000 1.939786069107 Long EC CORP US N 1 N N N Tetra Tech Inc 549300UJ1LP7JGJC5P32 Tetra Tech Inc 88162G103 182738.00000000 NS USD 27576991.58000000 1.330547847876 Long EC CORP US N 1 N N N Qualys Inc 549300EMBXYOW9W1XA17 Qualys Inc 74758T303 134548.00000000 NS USD 20579116.60000000 0.992911036865 Long EC CORP US N 1 N N N AvidXchange Holdings Inc N/A AvidXchange Holdings Inc 05368X102 2852990.00000000 NS USD 24649833.60000000 1.189316932989 Long EC CORP US N 1 N N N Manhattan Associates Inc 529900Q1GJP7KD52SW51 Manhattan Associates Inc 562750109 112962.00000000 NS USD 22025330.76000000 1.062688667705 Long EC CORP US N 1 N N N Remitly Global Inc N/A Remitly Global Inc 75960P104 2629786.00000000 NS USD 70820136.98000000 3.416963760231 Long EC CORP US N 1 N N N Appfolio Inc 529900OOUUGT6JFC0S15 Appfolio Inc 03783C100 145007.00000000 NS USD 27198962.99000000 1.312308544093 Long EC CORP US N 1 N N N RxSight Inc N/A RxSight Inc 78349D107 761286.00000000 NS USD 16854872.04000000 0.813221908343 Long EC CORP US N 1 N N N Comfort Systems USA Inc 5299009DT1ZA5HTU6R38 Comfort Systems USA Inc 199908104 226050.00000000 NS USD 41107192.50000000 1.983359437683 Long EC CORP US N 1 N N N Axon Enterprise Inc 549300QP2IEEGFE16681 Axon Enterprise Inc 05464C101 138480.00000000 NS USD 28317775.20000000 1.366289529432 Long EC CORP US N 1 N N N Monday.com Ltd 984500MDAFVD86E3B328 Monday.com Ltd 000000000 163115.00000000 NS USD 21203318.85000000 1.023027844856 Long EC CORP IL N 1 N N N Wingstop Inc 549300SSH3F8HPIM3Q47 Wingstop Inc 974155103 116590.00000000 NS USD 21309154.30000000 1.028134244146 Long EC CORP US N 1 N N N Duolingo Inc N/A Duolingo Inc 26603R106 383065.00000000 NS USD 55946643.25000000 2.699340337986 Long EC CORP US N 1 N N N Saia Inc 549300WNPG4N9GBOYB29 Saia Inc 78709Y105 96451.00000000 NS USD 34576718.99000000 1.668274035813 Long EC CORP US N 1 N N N Shake Shack Inc 529900J74GJAHYP80N79 Shake Shack Inc 819047101 200989.00000000 NS USD 11263423.56000000 0.543443034168 Long EC CORP US N 1 N N N Structure Therapeutics Inc N/A Structure Therapeutics Inc 86366E106 251644.00000000 NS USD 18697149.20000000 0.902108975785 Long EC CORP KY N 1 N N N EMCOR Group Inc 529900X0SQJB2J7YDU43 EMCOR Group Inc 29084Q100 195310.00000000 NS USD 40360811.50000000 1.947347691066 Long EC CORP US N 1 N N N CyberArk Software Ltd 529900YEXNDM894PWS93 CyberArk Software Ltd 000000000 212613.00000000 NS USD 34791991.32000000 1.678660597907 Long EC CORP IL N 1 N N N Varonis Systems Inc 549300SHIVNRRH7STS26 Varonis Systems Inc 922280102 839913.00000000 NS USD 28254673.32000000 1.363244959818 Long EC CORP US N 1 N N N TransMedics Group Inc 549300060GVOSMWARH50 TransMedics Group Inc 89377M109 248471.00000000 NS USD 9312693.08000000 0.449323259195 Long EC CORP US N 1 N N N Guidewire Software Inc 549300WXSG0J8IXZCK32 Guidewire Software Inc 40171V100 182165.00000000 NS USD 16418531.45000000 0.792169139360 Long EC CORP US N 1 N N N Guardant Health Inc 254900M8C3E5VC8BR186 Guardant Health Inc 40131M109 508081.00000000 NS USD 13149136.28000000 0.634425801234 Long EC CORP US N 1 N N N Fidelity Investments E57ODZWZ7FF32TWEFA76 Fidelity Investments Money Market Government Portfolio 31607A703 19934213.40000000 NS USD 19934213.40000000 0.961795439561 Long STIV RF US N 1 N N Intra-Cellular Therapies Inc 5299002U2KGF193IJA20 Intra-Cellular Therapies Inc 46116X101 438176.00000000 NS USD 21803637.76000000 1.051992318062 Long EC CORP US N 1 N N N Rambus Inc 2549000211GDCQSLV833 Rambus Inc 750917106 847793.00000000 NS USD 46060593.69000000 2.222353501771 Long EC CORP US N 1 N N N Krystal Biotech Inc 549300YONUY68210OE41 Krystal Biotech Inc 501147102 383313.00000000 NS USD 44797790.31000000 2.161425161757 Long EC CORP US N 1 N N N Freshworks Inc 254900ULRGCUEIK0K191 Freshworks Inc 358054104 1539573.00000000 NS USD 27619939.62000000 1.332620025402 Long EC CORP US N 1 N N N Axcelis Technologies Inc 529900HF9B6NL1QG9F05 Axcelis Technologies Inc 054540208 100054.00000000 NS USD 12756885.00000000 0.615500274318 Long EC CORP US N 1 N N N MSA Safety Inc 529900DVA3258XK11O39 MSA Safety Inc 553498106 221782.00000000 NS USD 35014942.16000000 1.689417636414 Long EC CORP US N 1 N N N AeroVironment Inc 529900PGHVI29YLZ6221 AeroVironment Inc 008073108 417140.00000000 NS USD 47829272.40000000 2.307689556081 Long EC CORP US N 1 N N N Karuna Therapeutics Inc N/A Karuna Therapeutics Inc 48576A100 66261.00000000 NS USD 11039745.21000000 0.532650894411 Long EC CORP US N 1 N N N Oddity Tech Ltd N/A Oddity Tech Ltd 000000000 385797.00000000 NS USD 9857113.35000000 0.475590708147 Long EC CORP IL N 1 N N Quanterix Corp N/A Quanterix Corp 74766Q101 468278.00000000 NS USD 10170998.16000000 0.490735172228 Long EC CORP US N 1 N N N Citibank NA E57ODZWZ7FF32TWEFA76 CITIBANK NA DDCA 000000000 2214912.60000000 NS USD 2214912.60000000 0.106866159951 Long STIV RF US N 1 N N Sterling Infrastructure Inc 549300RZIK6K1215XU51 Sterling Infrastructure Inc 859241101 312702.00000000 NS USD 22780340.70000000 1.099116747537 Long EC CORP US N 1 N N N Verra Mobility Corp 549300XX5EKGLR0M4152 Verra Mobility Corp 92511U102 1222170.00000000 NS USD 24162300.90000000 1.165794222657 Long EC CORP US N 1 N N N Bridgebio Pharma Inc 54930028YG89VTY2J114 Bridgebio Pharma Inc 10806X102 625177.00000000 NS USD 16279609.08000000 0.785466346567 Long EC CORP US N 1 N N N Nuvalent Inc N/A Nuvalent Inc 670703107 354904.00000000 NS USD 18486949.36000000 0.891967153610 Long EC CORP US N 1 N N N TechnipFMC PLC 549300D5I93QWCJTCK36 TechnipFMC PLC 000000000 1413311.00000000 NS USD 30414452.72000000 1.467451026829 Long EC CORP GB N 1 N N N Xenon Pharmaceuticals Inc 549300XV44Q9Z1MIPQ03 Xenon Pharmaceuticals Inc 98420N105 457227.00000000 NS USD 14174037.00000000 0.683875700195 Long EC CORP CA N 1 N N N Agilysys Inc 5299001XWB5V3B5IPN93 Agilysys Inc 00847J105 228366.00000000 NS USD 19591519.14000000 0.945260963391 Long EC CORP US N 1 N N N Flywire Corp 54930055DSV7NNY4VY66 Flywire Corp 302492103 1623449.00000000 NS USD 43654543.61000000 2.106265249485 Long EC CORP US N 1 N N N YETI Holdings Inc 549300DSQICIGNT5GO63 YETI Holdings Inc 98585X104 521495.00000000 NS USD 22173967.40000000 1.069860159233 Long EC CORP US N 1 N N N Integral Ad Science Holding Corp N/A Integral Ad Science Holding Corp 45828L108 1535517.00000000 NS USD 17627735.16000000 0.850511376922 Long EC CORP US N 1 N N N Arcellx Inc N/A Arcellx Inc 03940C100 757429.00000000 NS USD 26699372.25000000 1.288204051694 Long EC CORP US N 1 N N N Hayward Holdings Inc N/A Hayward Holdings Inc 421298100 1421246.00000000 NS USD 14923083.00000000 0.720016029004 Long EC CORP US N 1 N N N Shockwave Medical Inc 549300LDXO56IC5Y1538 Shockwave Medical Inc 82489T104 100898.00000000 NS USD 20811221.48000000 1.004109743862 Long EC CORP US N 1 N N N Sarepta Therapeutics Inc 549300IKDPIED8J8IG21 Sarepta Therapeutics Inc 803607100 122561.00000000 NS USD 8249580.91000000 0.398029715962 Long EC CORP US N 2 N N N Gitlab Inc N/A Gitlab Inc 37637K108 372952.00000000 NS USD 16141362.56000000 0.778796162507 Long EC CORP US N 1 N N N Allegro MicroSystems Inc N/A Allegro MicroSystems Inc 01749D105 467267.00000000 NS USD 12130251.32000000 0.585266153532 Long EC CORP US N 1 N N N Ventyx Biosciences Inc N/A Ventyx Biosciences Inc 92332V107 562853.00000000 NS USD 8116340.26000000 0.391601057506 Long EC CORP US N 1 N N N Descartes Systems Group Inc/The 875500NEPA7JI5EOMN45 Descartes Systems Group Inc/The 249906108 264616.00000000 NS USD 19107921.36000000 0.921928106957 Long EC CORP CA N 1 N N N Global-e Online Ltd N/A Global-e Online Ltd 000000000 1094039.00000000 NS USD 38411709.29000000 1.853306477641 Long EC CORP IL N 1 N N N Natera Inc N/A Natera Inc 632307104 428657.00000000 NS USD 16919091.79000000 0.816320413483 Long EC CORP US N 1 N N N NEXTracker Inc N/A NEXTracker Inc 65290E101 469267.00000000 NS USD 16311720.92000000 0.787015693945 Long EC CORP US N 1 N N N Aehr Test Systems 529900A4GWWZFRU2RE97 Aehr Test Systems 00760J108 393411.00000000 NS USD 9268763.16000000 0.447203707454 Long EC CORP US N 1 N N N XPO Inc 54930096DB9LCLPN7H13 XPO Inc 983793100 375476.00000000 NS USD 28464835.56000000 1.373384967850 Long EC CORP US N 1 N N N Cytokinetics Inc 549300BE5DY1HW7IHA64 Cytokinetics Inc 23282W605 551990.00000000 NS USD 19242371.40000000 0.928415116639 Long EC CORP US N 1 N N N Roku Inc 549300KR6ITU0YIR1T71 Roku Inc 77543R102 435543.00000000 NS USD 25945296.51000000 1.251821045589 Long EC CORP US N 1 N N N Immunovant Inc N/A Immunovant Inc 45258J102 310940.00000000 NS USD 10276567.00000000 0.495828707991 Long EC CORP US N 1 N N N Glaukos Corp 5299004JA1LHE21M6T14 Glaukos Corp 377322102 582238.00000000 NS USD 39708631.60000000 1.915881004069 Long EC CORP US N 1 N N N Clean Harbors Inc 5493000SJVZVZJKHJF48 Clean Harbors Inc 184496107 124689.00000000 NS USD 19160958.63000000 0.924487074467 Long EC CORP US N 1 N N N elf Beauty Inc 549300U2K9TCON25C029 elf Beauty Inc 26856L103 272432.00000000 NS USD 25235376.16000000 1.217568469810 Long EC CORP US N 1 N N N Deckers Outdoor Corp 5493008LG4W3I6K8J118 Deckers Outdoor Corp 243537107 33083.00000000 NS USD 19752535.98000000 0.953029780715 Long EC CORP US N 1 N N N Five9 Inc 254900MXP6EWY0SFFR59 Five9 Inc 338307101 171857.00000000 NS USD 9945364.59000000 0.479848696083 Long EC CORP US N 1 N N N Freshpet Inc 549300S4ZK8ZQ6HNPN59 Freshpet Inc 358039105 248840.00000000 NS USD 14283416.00000000 0.689153070377 Long EC CORP US N 1 N N N Extreme Networks Inc 549300WRECW11X94UB57 Extreme Networks Inc 30226D106 1265059.00000000 NS USD 26085516.58000000 1.258586450431 Long EC CORP US N 1 N N N Celsius Holdings Inc N/A Celsius Holdings Inc 15118V207 176171.00000000 NS USD 26793847.39000000 1.292762333326 Long EC CORP US N 1 N N N Lattice Semiconductor Corp 549300LRBBPZDQ2II567 Lattice Semiconductor Corp 518415104 412923.00000000 NS USD 22962648.03000000 1.107912798581 Long EC CORP US N 1 N N N AAON Inc N/A AAON Inc 000360206 395764.00000000 NS USD 21561222.72000000 1.040296161546 Long EC CORP US N 1 N N N Tenable Holdings Inc 5493004S5OMPESF0EF83 Tenable Holdings Inc 88025T102 792512.00000000 NS USD 33372680.32000000 1.610181003567 Long EC CORP US N 1 N N N Appian Corp 529900NIARIFW7HGU386 Appian Corp 03782L101 263021.00000000 NS USD 10378808.66000000 0.500761712387 Long EC CORP US N 1 N N N BellRing Brands Inc 549300S3BOK5CMTS8054 BellRing Brands Inc 07831C103 653727.00000000 NS USD 28587481.71000000 1.379302457815 Long EC CORP US N 1 N N N Confluent Inc 254900MRZ83YWUV7SN74 Confluent Inc 20717M103 1404180.00000000 NS USD 40594843.80000000 1.958639393143 Long EC CORP US N 1 N N N SPS Commerce Inc 2549006XVF9GCCETDQ72 SPS Commerce Inc 78463M107 146107.00000000 NS USD 23426796.38000000 1.130307249636 Long EC CORP US N 1 N N N Fixed Income Clearing Corp 549300H47WTHXPU08X20 FIXED INC CLEARING CORP.REPO 000000000 29351456.35000000 PA USD 29351456.35000000 1.416163070770 Long RA CORP US N 2 Repurchase N 2.80000000 2023-11-01 29963100.00000000 USD 29938520.99000000 USD UST N N N 2023-11-28 LORD ABBETT DEVELOPING GROWTH FUND, INC. Michael Hebert Michael Hebert Chief Financial Officer XXXX NPORT-EX 2 NPORT_EBX8_63981933_1023.htm

 

Lord Abbett
Quarterly Portfolio Holdings Report

 

Lord Abbett
Developing Growth Fund

 

For the period ended October 31, 2023

 

Schedule of Investments (unaudited)

October 31, 2023

 

Investments  Shares   Fair
Value
 
LONG-TERM INVESTMENTS 96.98%      
COMMON STOCKS 96.98%          
           
Aerospace & Defense 3.68%          
AeroVironment, Inc.*   417,140   $47,829,273 
Axon Enterprise, Inc.*   138,480    28,317,775 
Total        76,147,048 
           
Beverages 1.30%          
Celsius Holdings, Inc.*   176,171    26,793,847 
           
Biotechnology 8.60%          
Arcellx, Inc.*   757,429    26,699,372 
Bridgebio Pharma, Inc.*   625,177    16,279,609 
Cytokinetics, Inc.*   551,990    19,242,372 
Immunovant, Inc.*   310,940    10,276,567 
Karuna Therapeutics, Inc.*   66,261    11,039,745 
Krystal Biotech, Inc.*   383,313    44,797,790 
Natera, Inc.*   428,657    16,919,092 
Nuvalent, Inc. Class A*   354,904    18,486,949 
Xenon Pharmaceuticals, Inc. (Canada)*(a)   457,227    14,174,037 
Total        177,915,533 
           
Broadline Retail 1.86%          
Global-e Online Ltd. (Israel)*(a)   1,094,039    38,411,709 
           
Building Products 3.47%          
AAON, Inc.   395,764    21,561,223 
Hayward Holdings, Inc.*   1,421,246    14,923,083 
Trex Co., Inc.*   628,250    35,313,932 
Total        71,798,238 
           
Capital Markets 1.07%          
Piper Sandler Cos.   158,673    22,190,419 
           
Commercial Services & Supplies 3.95%      
Clean Harbors, Inc.*   124,689    19,160,959 
MSA Safety, Inc.   221,782    35,014,942 
Tetra Tech, Inc.   182,738    27,576,991 
Total        81,752,892 
Investments  Shares   Fair
Value
 
Communications Equipment 1.26%      
Extreme Networks, Inc.*   1,265,059   $26,085,517 
           
Construction & Engineering 5.04%         
Comfort Systems USA, Inc.   226,050    41,107,192 
EMCOR Group, Inc.   195,310    40,360,812 
Sterling Infrastructure, Inc.*   312,702    22,780,341 
Total        104,248,345 
           
Diversified Consumer Services 2.71%      
Duolingo, Inc.*   383,065    55,946,643 
           
Electrical Equipment 2.39%          
EnerSys   76,456    6,543,104 
NEXTracker, Inc. Class A*   469,267    16,311,721 
nVent Electric PLC (United Kingdom)(a)   551,074    26,523,192 
Total        49,378,017 
           
Energy Equipment & Services 1.47%      
TechnipFMC PLC (United Kingdom)(a)   1,413,311    30,414,453 
           
Entertainment 1.26%          
Roku, Inc.*   435,543    25,945,297 
           
Financial Services 6.73%          
AvidXchange Holdings, Inc.*   2,852,990    24,649,833 
Flywire Corp.*   1,623,449    43,654,544 
Remitly Global, Inc.*   2,629,786    70,820,137 
Total        139,124,514 
           
Food Products 0.69%          
Freshpet, Inc.*   248,840    14,283,416 
           
Ground Transportation 3.05%          
Saia, Inc.*   96,451    34,576,719 
XPO, Inc.*   375,476    28,464,836 
Total        63,041,555 

 

  See Notes to Schedule of Investments. 1
 

Schedule of Investments (unaudited)(continued)

October 31, 2023

 

Investments  Shares   Fair
Value
 
Health Care Equipment & Supplies 4.73%      
Glaukos Corp.*   582,238   $39,708,632 
iRhythm Technologies, Inc.*   140,941    11,066,687 
RxSight, Inc.*   761,286    16,854,872 
Shockwave Medical, Inc.*   100,898    20,811,222 
TransMedics Group, Inc.*   248,471    9,312,693 
Total        97,754,106 
           
Health Care Providers & Services 0.64%      
Guardant Health, Inc.*   508,081    13,149,136 
           
Hotels, Restaurants & Leisure 2.34%      
Cava Group, Inc.*(b)   502,995    15,889,612 
Shake Shack, Inc. Class A*   200,989    11,263,424 
Wingstop, Inc.   116,590    21,309,154 
Total        48,462,190 
           
Leisure Products 1.07%          
YETI Holdings, Inc.*   521,495    22,173,967 
           
Life Sciences Tools & Services 1.59%      
10X Genomics, Inc. Class A*   402,217    14,190,216 
Pacific Biosciences of California, Inc.*   1,364,427    8,432,159 
Quanterix Corp.*   468,278    10,170,998 
Total        32,793,373 
           
Media 0.85%          
Integral Ad Science Holding Corp.*   1,535,517    17,627,735 
           
Personal Care Products 4.04%          
BellRing Brands, Inc.*   653,727    28,587,482 
elf Beauty, Inc.*   272,432    25,235,376 
Inter Parfums, Inc.   155,453    19,759,631 
Oddity Tech Ltd. Class A (Israel)*(a)(b)   385,797    9,857,113 
Total        83,439,602 
Investments  Shares   Fair
Value
 
Pharmaceuticals 2.35%          
Intra-Cellular Therapies, Inc.*   438,176   $21,803,638 
Structure Therapeutics, Inc. Add ADR*   251,644    18,697,149 
Ventyx Biosciences, Inc.*   562,853    8,116,340 
Total        48,617,127 
           
Professional Services 1.61%          
Upwork, Inc.*   869,858    9,090,016 
Verra Mobility Corp.*   1,222,170    24,162,301 
Total        33,252,317 
           
Semiconductors & Semiconductor Equipment 3.88% 
Aehr Test Systems*   393,411    9,268,763 
Allegro MicroSystems, Inc.*   467,267    12,130,251 
Axcelis Technologies, Inc.*   100,054    12,756,885 
Rambus, Inc.*   847,793    46,060,594 
Total        80,216,493 
           
Software 21.69%          
Agilysys, Inc.*   244,307    20,959,097 
Appfolio, Inc. Class A*   145,007    27,198,963 
Appian Corp. Class A*   263,021    10,378,809 
Confluent, Inc. Class A*   1,404,180    40,594,844 
CyberArk Software Ltd. (Israel)*(a)   212,613    34,791,991 
Descartes Systems Group, Inc. (Canada)*(a)   264,616    19,107,921 
DoubleVerify Holdings, Inc.*   591,906    16,472,744 
Five9, Inc.*   171,857    9,945,365 
Freshworks, Inc. Class A*   1,539,573    27,619,940 
Gitlab, Inc. Class A*   372,952    16,141,363 
Guidewire Software, Inc.*   182,165    16,418,531 
JFrog Ltd. (Israel)*(a)   879,440    19,778,606 
Manhattan Associates, Inc.*   112,962    22,025,331 

 

2 See Notes to Schedule of Investments.
 

Schedule of Investments (unaudited)(continued)

October 31, 2023

 

Investments  Shares   Fair
Value
 
Software (continued)          
Monday.com Ltd. (Israel)*(a)   163,115   $21,203,319 
Qualys, Inc.*   134,548    20,579,117 
Samsara, Inc. Class A*   1,742,700    40,204,089 
SPS Commerce, Inc.*   146,107    23,426,796 
Tenable Holdings, Inc.*   792,512    33,372,680 
Varonis Systems, Inc.*   839,913    28,254,673 
Total        448,474,179 
           
Technology Hardware, Storage & Peripherals 1.30% 
Super Micro Computer, Inc.*   112,240    26,878,113 
           
Textiles, Apparel & Luxury Goods 0.96% 
Deckers Outdoor Corp.*   33,083    19,752,536 
           
Trading Companies & Distributors 1.40% 
SiteOne Landscape Supply, Inc.*   210,692    29,027,037 
Total Common Stocks
(cost $1,940,494,628)
        2,005,095,354 
           
   Principal
Amount
      
           
SHORT-TERM INVESTMENTS 2.49%      
           
Repurchase Agreements 1.42%      
Repurchase Agreement dated 10/31/2023, 2.800% due 11/1/2023 with Fixed Income Clearing Corp. collateralized by $29,963,100 of U.S. Treasury Note at 5.000% due 10/31/2025; value: $29,938,521; proceeds: $29,353,739
(cost $29,351,456)
  $29,351,456    29,351,456 
Investments  Shares   Fair
Value
 
Money Market Funds 0.96%          
Fidelity Government Portfolio(c)
(cost $19,934,213)
   19,934,213   $19,934,213 
           
Time Deposits 0.11%          
CitiBank N.A.(c)
(cost $2,214,913)
   2,214,913    2,214,913 
Total Short-Term Investments
(cost $51,500,582)
        51,500,582 
Total Investments in Securities 99.47%
(cost $1,991,995,210)
        2,056,595,936 
Other Assets and Liabilities – Net 0.53%        11,027,537 
Net Assets 100.00%       $2,067,623,473 

 

ADR   American Depositary Receipt.
*   Non-income producing security.
(a)   Foreign security traded in U.S. dollars.
(b)   All or a portion of this security is temporarily on loan to unaffiliated broker/dealers.
(c)   Security was purchased with the cash collateral from loaned securities.

 

  See Notes to Schedule of Investments. 3
 

Schedule of Investments (unaudited)(concluded)

October 31, 2023

 

The following is a summary of the inputs used as of October 31, 2023 in valuing the Fund’s investments carried at fair value(1):

 

Investment Type(2)  Level 1   Level 2   Level 3   Total 
Long-Term Investments                    
Common Stocks  $2,005,095,354   $   $   $2,005,095,354 
Short-Term Investments                    
Repurchase Agreements       29,351,456        29,351,456 
Money Market Funds   19,934,213            19,934,213 
Time Deposits       2,214,913        2,214,913 
Total  $2,025,029,567   $31,566,369   $   $2,056,595,936 

 

(1)   Refer to Note 2(b) for a description of fair value measurements and the three-tier hierarchy of inputs.
(2)   See Schedule of Investments for fair values in each industry and identification of foreign issuers and/or geography. When applicable, each Level 3 security is identified on the Schedule of Investments along with the valuation technique utilized.

 

A reconciliation of Level 3 investments is presented when the Fund has a material amount of Level 3 investments at the beginning or end of the period in relation to the Fund’s net assets.

 

4 See Notes to Schedule of Investments.
 

Notes to Schedule of Investments (unaudited)

 

1. ORGANIZATION  

 

Lord Abbett Developing Growth Fund, Inc. (the “Fund”) is registered under the Investment Company Act of 1940, as amended (the “Act”), as a diversified, open-end management investment company. The Fund was incorporated under Maryland law on August 21, 1978. The Fund’s predecessor corporation was organized on July 11, 1973.

 

The Fund’s investment objective is long-term growth of capital through a diversified and actively managed portfolio consisting of developing growth companies, many of which are traded over the counter.

 

2. SIGNIFICANT ACCOUNTING POLICIES 

 

(a) Investment Valuation-Under procedures approved by the Fund’s Board of Directors (the “Board”), the Board has designated the determination of fair value of the Fund’s portfolio investments to Lord, Abbett & Co. LLC (“Lord Abbett”) as its valuation designee. Accordingly, Lord Abbett is responsible for, among other things, assessing and managing valuation risks, establishing, applying and testing fair value methodologies, and evaluating pricing services. Lord Abbett has formed a Pricing Committee that performs these responsibilities on behalf of Lord Abbett, administers the pricing and valuation of portfolio investments and ensures that prices utilized reasonably reflect fair value. Among other things, these procedures allow Lord Abbett, subject to Board oversight, to utilize independent pricing services, quotations from securities and financial instrument dealers and other market sources to determine fair value.
   
  Securities actively traded on any recognized U.S. or non-U.S. exchange or on The NASDAQ Stock Market LLC are valued at the last sale price or official closing price on the exchange or system on which they are principally traded. Events occurring after the close of trading on non-U.S. exchanges may result in adjustments to the valuation of foreign securities to reflect their fair value as of the close of regular trading on the New York Stock Exchange. When valuing foreign equity securities that meet certain criteria, the Pricing Committee uses a third-party fair valuation service that values such securities to reflect market trading that occurs after the close of the applicable foreign markets of comparable securities or other instruments that correlate to the fair-valued securities. Unlisted equity securities are valued at the last quoted sale price or, if no sale price is available, at the mean between the most recently quoted bid and ask prices.
   
  Securities for which prices are not readily available are valued at fair value as determined by the Pricing Committee. The Pricing Committee considers a number of factors, including observable and unobservable inputs, when arriving at fair value. The Pricing Committee may use related or comparable assets or liabilities, recent transactions, market multiples, book values, and other relevant information to determine the fair value of portfolio investments. The Board or a designated committee thereof periodically reviews reports that may include fair value determinations made by the Pricing Committee, related market activity, inputs and assumptions, and retrospective comparison of prices of subsequent purchases and sales transactions to fair value determinations made by the Pricing Committee.
   
  Short-term securities with 60 days or less remaining to maturity are valued using the amortized cost method, which approximates fair value. Investments in open-end money market mutual funds are valued at their NAV as of the close of each business day.

 

5

 

Notes to Schedule of Investments (unaudited)(continued)

 

(b) Fair Value Measurements-Fair value is defined as the price that the Fund would receive upon selling an investment or transferring a liability in an orderly transaction to an independent buyer in the principal or most advantageous market of the investment. A three-tier hierarchy is used to maximize the use of observable market data and minimize the use of unobservable inputs and to establish classification of fair value measurements for disclosure purposes. Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability, including assumptions about risk - for example, the risk inherent in a particular valuation technique used to measure fair value (such as a pricing model) and/or the risk inherent in the inputs to the valuation technique. Inputs may be observable or unobservable. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability. Observable inputs are based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the reporting entity’s own assumptions about the assumptions market participants would use in pricing the asset or liability. Unobservable inputs are based on the best information available in the circumstances. The three-tier hierarchy classification is determined based on the lowest level of inputs that is significant to the fair value measurement, and is summarized in the three broad Levels listed below:

 

Level 1 –  unadjusted quoted prices in active markets for identical investments;
     
Level 2 –  other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.); and
     
Level 3 –  significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments).
 
A summary of inputs used in valuing the Fund’s investments as of October 31, 2023 and, if applicable, Level 3 rollforwards for the period then ended is included in the Fund’s Schedule of Investments.
 
Changes in valuation techniques may result in transfers into or out of an assigned level within the three-tier hierarchy. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

 

3. FEDERAL TAX INFORMATION  

 

It is the policy of the Fund to meet the requirements of Subchapter M of the Internal Revenue Code applicable to regulated investment companies and to distribute substantially all taxable income and capital gains to its shareholders. Therefore, no income tax provision is required.

 

The Fund files U.S. federal and various state and local tax returns. No income tax returns are currently under examination. The statute of limitations on the Fund’s filed U.S. federal tax returns remains open generally three years after the filing of the tax return. The statute of limitations on the Fund’s, state and local tax returns may remain open for an additional year depending upon the jurisdiction.

 

4. SECURITIES LENDING AGREEMENT  

 

The Fund has established a securities lending agreement with Citibank, N.A. for the lending of securities to qualified brokers in exchange for securities or cash collateral equal to at least the market value of securities loaned, plus interest, if applicable. Cash collateral is invested in an approved money market fund. In accordance with the Fund’s securities lending agreement, the

 

6

 

Notes to Schedule of Investments (unaudited)(concluded)

 

market value of securities on loan is determined each day at the close of business and any additional collateral required to cover the value of securities on loan is delivered to the Fund on the next business day. As with other extensions of credit, the Fund may experience a delay in the recovery of its securities or incur a loss should the borrower of the securities breach its agreement with the Fund or the borrower becomes insolvent at a time when the collateral is insufficient to cover the cost of repurchasing securities on loan.

 

The initial collateral received by the Fund is required to have a value equal to at least 100% of the market value of the securities loaned. The collateral must be marked-to-market daily to cover increases in the market value of the securities loaned (or potentially a decline in the value of the collateral). In general, the risk of borrower default will be borne by Citibank, N.A.; the Fund will bear the risk of loss with respect to the investment of the cash collateral. The advantage of such loans is that the Fund continues to receive income on loaned securities while receiving a portion of any securities lending fees and earning returns on the cash amounts which may be reinvested for the purchase of investments in securities.

 

As of October 31, 2023, the market value of securities loaned and collateral received for the Fund were as follows:

 

Market Value of
Securities Loaned
  Collateral Received  
$21,577,005             $22,149,126  

 

7

 

 

QPHR-DEV-1Q
(12/23)

 
GRAPHIC 3 x2_c107283x1x1.jpg begin 644 x2_c107283x1x1.jpg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end